The Increasing Burden of Diseases in the World Is Augmenting the Growth of the Global Human Combination Vaccines Market

 

Human Combination Vaccines Market
Human Combination Vaccines Market

Human Combination Vaccines Market, by Product Type (Inactivated Vaccine and Live Attenuated Vaccine), by Age Group (Children and Adults), by Combination Type (DTaP/IPV/Hep B, DTaP/Hib/IPV, MMR II, Hep B-Hib, and Others), by Distribution Channel (Hospital pharmacies, Retail pharmacies, and Online Pharmacies) and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028.

Market Overview:

Human combination vaccines are vaccines that incorporate multiple antigens or immunogens to protect against multiple diseases in a single vaccine formulation. These vaccines are designed to simplify the vaccination process by reducing the number of injections required and improving patient compliance. Rather than administering separate vaccines for each disease, a combination vaccine combines antigens from different pathogens into a single vaccine product.

Competitive Landscape:

Major players operating in the global human combination vaccines market include NPS MedicineWise, Takeda Pharmaceutical Co. Ltd., CNBG, Emergent BioSolutions Inc, PaxVax Corporation, Biological, Influvac, AstraZeneca, Moderna, Serum Institute of India, Meiji Holdings Co. Ltd, Mass Biologics, Crunchbase Inc., Merck & Co., DAIICHI SANKYO COMPANY, LIMITED, Mitsubishi Tanabe Pharma Corp., CSL Ltd., GlaxoSmithKline plc, Cadila Healthcare Ltd., Pfizer Inc., and Sanofi.

Key Market Drivers:

Combination vaccines offer convenience by delivering protection against multiple diseases in a single administration. This simplifies vaccination schedules, reduces the number of healthcare visits, and improves patient compliance, especially in pediatric populations. This is expected to augment the growth of the global human combination vaccines market.

Human combination vaccines ensure broader protection against multiple diseases, including measles, mumps, rubella, diphtheria, pertussis, tetanus, and others. The comprehensive coverage provided by combination vaccines is a significant driver for their adoption, particularly in regions with high disease burdens. For instance, in May 2020, International AIDS Vaccine Initiative and Merck & Co., Inc. partnered in order to develop a novel vaccine candidate for COVID-19.

Combination vaccines offer cost advantages by reducing the number of individual vaccines required and associated healthcare visits. This is particularly beneficial in resource-constrained settings, where it streamlines immunization programs and optimizes healthcare resources.

Advances in vaccine technology have facilitated the development of safe and effective combination vaccines. The introduction of newer adjuvants, improved antigen selection, and formulation techniques have enhanced vaccine efficacy, which is estimated to enhance the growth of the global human combination vaccines market.

Covid-19 Impact Analysis:

The urgency of the COVID-19 pandemic has led to a surge in vaccine research and development efforts worldwide. This heightened focus on vaccines, including novel technologies such as mRNA vaccines, has accelerated advancements in the field and could have long-term positive implications for the global human combination vaccines market.  For instance, in 2020, Sanofi Pasteur extended its partnership with Translate Bio, in order to create a novel mRNA vaccine candidate for COVID-19.

Key Takeaways:

·         North America is expected to dominate the growth of the global human combination vaccines market, owing to robust healthcare infrastructure, high awareness about vaccination, and strong immunization programs. The region also benefits from extensive research and development activities in the field. For instance, in July 2020, Medicago and GSK partnered in order to introduce a COVID-19 adjuvant vaccine candidate.

·         The Asia Pacific is estimated to witness high growth in the global human combination vaccines market, owing to a large population, high disease burden, and increasing investments in healthcare infrastructure. Government initiatives to improve vaccination coverage and growing awareness about immunization further fuel market growth. For instance, according to AmbitionBox, there are 175 major biotechnology companies in India.

Comments

Post a Comment

Popular posts from this blog

Flavors and Fragrances Market: A Comprehensive Analysis of Current Trends and Future Outlook

Image
  Flavors and Fragrances Market Introduction: The global flavors and fragrances market has witnessed remarkable growth in recent years, driven by increasing consumer preferences for enhanced sensory experiences in various industries. Flavors and fragrances play a vital role in food and beverages, personal care products, household products, and the pharmaceutical industry. This report provides an in-depth analysis of the flavors and fragrances market, highlighting key trends, market dynamics, and future prospects. Market Overview: The flavors and fragrances market has experienced substantial growth, with a projected CAGR of X% from 2023 to 2028. The market is primarily driven by rising disposable incomes, urbanization, and changing consumer lifestyles. Key market players are continually investing in research and development activities to introduce innovative flavors and fragrances that cater to evolving consumer demands. Segmentation and Key Market Players: The market can be
Read more

Exploring the Different Types of Blood Clotting Factors and Their Functions

Image
  Blood Clotting Factor Coagulation, another name for blood clotting, is a complicated process that is essential for reducing excessive bleeding after an injury. It entails a chain of events that cause a blood clot to develop, sealing the injured blood artery and stopping further bleeding. Blood clotting factors are a group of proteins that control these processes. Roman numerals from I to XIII are used to identify each of the 13 distinct blood clotting factors. The liver makes them, and platelets, the tiny blood cells that aid in blood clotting, also make some of them. Each of these elements interacts with the others in a series of reactions, activating the one before it. Factor I : Also known as fibrinogen, is a protein that is converted into fibrin, the main component of a blood clot. Factor II, also known as prothrombin, is converted into thrombin, which converts fibrinogen into fibrin. Factor III, also known as tissue factor, is released by damaged tissue and initiates the clo
Read more

Angioplasty Balloons Market Size, Share, Trend Analysis & Competition Tracking, Forecast 2018-2026

Image
                Angioplasty Balloons Market Angioplasty balloons are medical devices that are used during surgical procedures to unblock and enlarge congested blood arteries. Drug-eluting, normal, scoring, and cutting balloons are some of the most popular types of angioplasty balloons. They're made of nylon, polyurethane, and silicone urethane polymers, and they have nitinol constraining structures on the balloon's surface that generate grooves and pillows for predictable, uniform, and atraumatic dilation. The balloon is inflated during surgery to flatten the plaque against the blood artery walls, opening them and restoring normal blood flow. According to a survey conducted by the Health Protection Agency in 2016, around 610,000 individuals die in the United States each year as a result of cardiac abnormalities, with the number continuing to rise. According to the World Health Organization (WHO), the United States had roughly 8 million people with peripheral artery disease in
Read more